Low frequencies of resistance among Staphylococcus and Enterococcus species to the bactericidal DNA polymerase inhibitor N3-hydroxybutyl 6-(3′-ethyl-4′-methylanilino) uracil

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 12, 2002, Pages 3770-3775

  Butler, Michelle M ^a   Skow, Donna J ^a   Stephenson, Ryan O ^a,b   Lyden, Patrick T ^a   LaMarr, William A ^a   Foster, Kimberly A ^a  

^a MICROBIOTIX INC   (United States)

^b UNIVERSITY OF NEW ENGLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIBIOTIC AGENT; CIPROFLOXACIN; DNA POLYMERASE; ENZYME INHIBITOR; GENTAMICIN; N 3 HYDROXYBUTYL 6 (3' ETHYL 4' METHYLANILINO)URACIL; POL PROTEIN; RIFAMPICIN; UNCLASSIFIED DRUG; URACIL DERIVATIVE; ANTIINFECTIVE AGENT; DNA DIRECTED DNA POLYMERASE GAMMA; DRUG DERIVATIVE; URACIL;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CODON; CONTROLLED STUDY; DNA SEQUENCE; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENZYME INHIBITION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STRUCTURAL GENE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; MICROBIOLOGICAL EXAMINATION; STAPHYLOCOCCUS; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; DNA POLYMERASE III; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS; STRUCTURE-ACTIVITY RELATIONSHIP; URACIL;

EID: 0036895515     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.12.3770-3775.2002     Document Type: Article

References (24)

1. Aeschlimann, J. R., E. Hershberger, and M. J. Rybak. 1999. Analysis of vancomycin population susceptibility profiles, killing activity, and postantibiotic effect against vancomycin-intermediate Staphylococcus aureus. Antimicrob, Agents Chemother. 43:1914-1918,
2. Barnes, M. H., and N. C. Brown. 1979. Antibody to B. subtilis DNA polymerase III: Use in the purification of enzyme and the study of its structure. Nucleic Acids Res. 6:1203-1219.
3. Barnes, M. H., C. Leo, and N. C. Brown. 1998. DNA polymerase III of gram-positive eubacteria is a zinc metalloprotein conserving an essential finger-like domain. Biochemistry 37:15254-15260.
4. Barnes, M. H., R. A. Hammond, C. C. Kennedy, S. L. Mack, and N. C. Brown. 1992. Localization of the exonuclease and polymerase domains of Bacillus subtilis DNA polymerase III, Gene 111:43-49.
5. Brown, N. C., J. J. Gambino, and G. E. Wright. 1977. Inhibitors of Bacillus subtilis DNA polymerase III. 6-(arylalkylamino) uracils and 6-anilinouracils. J. Med. Chem. 20:1186-1189.
6. Brown, N. C., L. W. Dudycz, and G. E. Wright. 1986. Rational design of substrate analogues targeted to selectively inhibit replication-specific DNA polymerases. Drugs Exp. Clin. Res. 12:555-564.
7. Centers for Disease Control and Prevention. 2002. Staphylococcus Aureus Resistant To Vancomycin - United States. Morb. Mortal. Wkly. Rep. [Online.] http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5126a1.htm.
8. Cozzarelli, N. R. 1977. The mechanism of action of inhibitors of DNA synthesis. Annu. Rev. Biochem. 46:641-668.
9. Daly, J. S., T. J. Giehl, N. C. Brown, C. Zhi, G. E. Wright, and R. T. Ellison III. 2000. In vitro antimicrobial activities of novel anilinouracils which selectively inhibit DNA polymerase III of gram-positive bacteria. Antimicrob. Agents Chemother. 44:2217-2221.
10. Evans, M. E., and W. B. Titlow. 1998. Selection of fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus with ciprofloxacin and trovafloxacin. Antimicrob. Agents Chemother. 42:727.
11. Gass, K. B., and N. R. Cozzarelli. 1973. Further genetic and enzymological characterization of the three Bacillus subtilis deoxyribonucleic acid polymerases. J. Biol. Chem. 248:7688-7700.
12. Huang, Y.-P., and J. Ito. 1998. The hyperthermophilic bacterium Thermotogamaritima has two different classes of family C DNA polymerases: evolutionary implications. Nucleic Acids Res. 26:5300-5309.
13. Huycke, M. M., D. F. Sahm, and M. S. Gilmore. 1998. Multiple-drug resistant enterococci: The nature of the problem and an agenda for the future. Emerg. Infect. Dis. 4:239-249.
14. Ince, D., and D. C. Hooper. 2000. Mechanisms and frequency of resistance to premafloxacin in Staphylococcus aureus: Novel mutations suggest novel drug-target interactions. Antimicrob. Agents Chemother. 44:3344-3350.
15. Jones, R. N., and M. A. Pfaller. 1998. Bacterial resistance: A worldwide problem. Diagn. Microbiol. Infect. Dis. 31:379-388.
16. Kornberg, A., and T. A. Baker. 1992. DNA Replication. W. H. Freeman & Co., New York, N.Y.
17. Love, E., J. D'Ambrosio, N. C. Brown, and D. Dubnau. 1976. Mapping of the gene specifying DNA polymerase III of B. subtilis. Mol. Gen. Genet. 144: 313-321.
18. Michel, M., and L. Gutmann. 1997. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Therapeutic realities and possibilities. Lancet 349:1901-1906.
19. Small, P. M., and H. F. Chambers. 1990. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob. Agents Chemother. 34:1227-1231.
20. Tarantino, P. M., C. Zhi, G. E. Wright, and N. C. Brown. 1999. Inhibitors of DNA polymerase III as novel antibacterial agents against gram-positive eubacteria. Antimicrob. Agents Chemother. 43:1982-1987.
21. Tarantino, P. M., C. Zhi, J. J. Gambino, G. E. Wright, and N. C. Brown. 1999. 6-Anilinouracil-based inhibitors of Bacillus subtilis DNA polymerase III; antipolymerase and antimicrobial structure-activity relationships based on substitution at uracil N-3. J. Med. Chem. 42:2035-2040.
22. Tomasz, A. 1994. Multiple-antibiotic-resistant bacteria. N. Engl. J. Med. 330:1247-1251.
23. Wright, G. E., and N. C. Brown. 1976. The mechanism of inhibition of B. subtilis DNA polymerase III by 6-(arylhydrazino) pyrimidines: Novel properties of 2-thiouracil derivatives. Biochim. Biophys. Acta 432:37-48.
24. Wright, G. E., and N. C. Brown. 1999. DNA polymerase III: A new target for antibiotic development. Curr. Opin. Anti-Infect. Investig. Drugs 1:45-48.